Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: Role of lowering circulating lipids

British Journal of Pharmacology

Volumn 145, Issue 6, 2005, Pages 767-774

  Huang, Tom Hsun Wei ^a   Peng, Gang ^a   Kota, Bhavani Prasad ^a   Li, George Qian ^a   Yamahara, Johji ^b   Roufogalis, Basil D ^a   Li, Yuhao ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Pharmafood Institute   (Japan)

Author keywords

Diabetes; Fatty acid; Gene; Lipid metabolism; Myocardium; Oxidation; PPAR ; Punica granatum

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 4 O METHYLPHORBOL 13 ACETATE 12 MYRISTATE; 5' ADENOSINE MONOPHOSPHATE ACTIVATED PROTEIN KINASE 2; ACYL COENZYME A OXIDASE; CARNITINE PALMITOYLTRANSFERASE; CARRIER PROTEIN; CHOLESTEROL; FATTY ACID; FENOFIBRATE; GALLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; OLEANOLIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PUNICA GRANATUM EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MODEL; GENE OVEREXPRESSION; HEART DISEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIPID BLOOD LEVEL; MALE; MEDICINAL PLANT; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION KINETICS; POMEGRANATE; PRIORITY JOURNAL; RAT; REPORTER GENE;

ACYL-COA OXIDASE; ANIMALS; CARNITINE O-PALMITOYLTRANSFERASE; CELL LINE; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; FATTY ACID TRANSPORT PROTEINS; FATTY ACIDS, NONESTERIFIED; FLOWERS; GENE EXPRESSION REGULATION; HEART; HEART VENTRICLES; HUMANS; HYPERLIPIDEMIAS; MALE; MEMBRANE TRANSPORT PROTEINS; MULTIENZYME COMPLEXES; MYOCARDIUM; PLANT EXTRACTS; PPAR ALPHA; PROTEIN-SERINE-THREONINE KINASES; PUNICACEAE; RATS; RATS, ZUCKER; RNA, MESSENGER; TRIGLYCERIDES;

EID: 23044510556     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706245     Document Type: Article

References (39)

1. AASUM, E., BELKE, D.D., SEVERSON, D.L., RIEMERSMA, R.A., COOPER, M., ANDREASSEN, M. & LARSEN, T.S. (2002). Cardiac function and metabolism in type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-alpha activator. Am. J. Physiol. Heart Circ. Physiol., 283, H949-H957.
2. ABE, A., KIRIYAMA, Y., HIRANO, M., MIURA, T., KAMIYA, H., HARASHIMA, H. & TOKUMITSU, Y. (2002). Troglitazone suppresses cell growth of KU812 cells independently of PPARgamma. Eur. J. Pharmacol., 436, 7-13.
3. AMEEN, C., EDVARDSSON, U., LJUNGBERG, A., ASP, L., AKERBLAD, P., TUNELD, A., OLOFSSON, S.O., LINDEN, D. & OSCARSSON, J. (2005). Activation of peroxisome proliferator-activated receptor alpha increases the expression and activity of microsomal triglyceride transfer protein in the liver. J. Biol. Chem., 280, 1224-1229.
4. ATKINSON, L.L., KOZAK, R., KELLY, S.E., ONAY BESIKCI, A., RUSSELL, J.C. & LOPASCHUK, G.D. (2003). Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats. Am. J. Physiol. Endocrinol. Metab., 284, E923-E930.
5. AVIRAM, M., DORNFELD, L., KAPLAN, M., COLEMAN, R., GAITINI, D., NITECKI, S., HOFMAN, A., ROSENBLAT, M., VOLKOVA, N., PRESSER, D., ATTIAS, J., HAYEK, T. & FUHRMAN, B. (2002). Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. Drugs. Exp. Clin. Res., 28, 49-62.
6. BRAMLETT, K.S., HOUCK, K.A., BORCHERT, K.M., DOWLESS, M.S., KULANTHAIVEL, P., ZHANG, Y., BEYER, T.P., SCHMIDT, R., THOMAS, J.S., MICHAEL, L.F., BARR, R., MONTROSE, C., EACHO, P.I., CAO, G. & BURRIS, T.P. (2003). A natural product ligand of the oxysterol receptor, liver X receptor. J. Pharmacol. Exp. Ther., 307, 291-296.
7. CHRISTOFFERSEN, C., BOLLANO, E., LINDEGAARD, M.L., BARTELS, E.D., GOETZE, J.P., ANDERSEN, C.B. & NIELSEN, L.B. (2003). Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology, 144, 3483-3490.
8. COORT, S.L., HASSELBAINK, D.M., KOONEN, D.P., WILLEMS, J., COUMANS, W.A., CHABOWSKI, A., VAN DER VUSSE, G.J., BONEN, A., GLATZ, J.F. & LUIKEN, J.J. (2004). Enhanced sarcolemmal FAT/CD 3 6 content and triacylglycerol storage in cardiac myocytes from obese zucker rats. Diabetes, 53, 1655-1663.
9. ESCHER, P. & WAHLI, W. (2000). Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat Res., 448, 121-138.
10. ESMAILLZADEH, A., TAHBAZ, F., GAIENI, I., ALAVI-MAJD, H. & AZADBAKHT, L. (2004). Concentrated pomegranate juice improves lipid profiles in diabetic patients with hyperlipidemia. J. Med. Food, 7, 305-308.
11. FINCK, B.N., LEHMAN, J.J., LEONE, T.C., WELCH, M.J., BENNETT, M.J., KOVACS, A., HAN, X., GROSS, R.W., KOZAK, R., LOPASCHUK, G.D. & KELLY, D.P. (2002). The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J. Clin. Invest., 109, 121-130.
12. FRANCIS, G.A., ANNICOTTE, J.S. & AUWERX, J. (2003). PPAR-alpha effects on the heart and other vascular tissues. Am. J. Physiol. Heart. Circ. Physiol., 285, H1-H9.
13. FREDERIKSEN, K.S., WULFF, E.M., SAUERBERG, P., MOGENSEN, J.P., JEPPESEN, L. & FLECKNER, J. (2004). Prediction of PPAR-alpha ligand-mediated physiological changes using gene expression profiles. J. Lipid Res., 45, 592-601.
14. GIL, M.I., TOMAS-BARBERAN, F.A., HESS-PIERCE, B., HOLCROFT, D.M. & KADER, A.A. (2000). Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J. Agric. Food. Chem., 48, 4581-4589.
15. HUANG, T.H., PENG, G., KOTA, B.P., LI, Q., YAMAHARA, J., ROUFOGALIS, BD. & LI, Y. (2005). Anti-diabetic action of Punica granatum flower extract: activation of PPAR-γ and identification of an active component. Toxcol. Appl. Pharm., in press.
16. JAFRI, M.A., ASLAM, M., JAVED, K. & SINGH, S. (2000). Effect of Punica granatum Linn., (flowers) on blood glucose level in normal and alloxan-induced diabetic rats. J. Ethnopharmacol., 70, 309-314.
17. JEONG, H.G. (1999). Inhibition of cytochrome P450 2E1 expression by oleanolic acid: hepatoprotective effects against carbon tetrachloride-induced hepatic injury. Toxicol. Lett., 105, 215-222.
18. JURJANI, M.I. (1878). Zakheera-Khwarzam-Shahi. Lucknow: Munshi Nawal Kishore. 540 (Urdu translation).
19. KEHRER, J.P., BISWAL, S.S., LA, E., THUILLIER, P., DATTA, K., FISCHER, S.M. & VANDEN HEUVEL, J.P. (2001). Inhibition of peroxisome-proliferator- activated receptor (PPAR) alpha by MK886. Biochem. J., 356, 899-906.
20. KROES, B.H., VAN DEN BERG, A.J., QUARLES VAN UFFORD, H.C., VAN DIJK, H. & LABADIE, R.P. (1992). Anti-inflammatory activity of gallic acid. Planta Med., 58, 499-504.
21. LARSEN, P.J., JENSEN, P.B., SORENSEN, R.V., LARSEN, L.K., VRANG, N., WULFF, E.M. & WASSERMANN, K. (2003). Differential influences of peroxisome proliferator-activated receptors gamma and -alpha on food intake and energy homeostasis. Diabetes, 52, 224922-224959.
22. LI, Y., WEN, S., KOTA, B.P., PENG, G., LI, Q., YAMAHARA, J. & ROUFOGALIS, B.D. (2005). Punica granatum flower extract, a potent α-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats. J. Ethnopharmacol., in press.
23. LIU, J. (1995). Pharmacology of oleanolic acid and ursolic acid. J. Ethnopharmacol., 49, 57-68.
24. LIU, J., LIU, Y., PARKINSON, A. & KLAASSEN, C.D. (1995). Effect of oleanolic acid on hepatic toxicant-activating and detoxifying systems in mice. J. Pharmacol. Exp. Ther., 275, 768-774.
25. LOPASCHUK, G.D. (2002). Metabolic abnormalities in the diabetic heart. Heart, Fail. Rev., 1, 149-159.
26. MAJOOSI, A.I.A. (1889). Kamilussanah. Lucknow: Munshi Nawal Kishore. 145 Urdu translation.
27. NEITZEL, A.S., CARLEY, A.N. & SEVERSON, D.L. (2003). Chylomicron and palmitate metabolism by perfused hearts from diabetic mice. Am. J. Physiol. Endocrinol. Metab., 284, E357-E365.
28. NIELSEN, L.B., BARTELS, E.D. & BOLLANO, E. (2002). Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice. J. Biol. Chem., 277, 27014-27020.
29. OAKES, N.D., THALEN, P.G., JACINTO, S.M. & LJUNG, B. (2001). Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability. Diabetes, 50, 1158-1165.
30. PEREZ-CAMINO, M.C. & CERT, A. (1999). Quantitative determination of hydroxy pentacyclic triterpene acids in vegetable oils. J. Agric. Food. Chem., 47, 1558-1562.
31. RODRIGUES, B., CAM, M.C. & MCNEILL, J.H. (1998). Metabolic disturbances in diabetic cardiomyopathy. Mol. Cell Biochem., 180, 53-57.
32. SCHAFFER, J.E. & LODISH, H.F. (1994). Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell, 79, 427-436.
33. SCHUBERT, S.Y., NEEMAN, I. & RESNICK, N. (2002). A novel mechanism for the inhibition of NF-kappaB activation in vascular endothelial cells by natural antioxidants. FASEB J., 16, 1931-1933.
34. STANLEY, W.C., LOPASCHUK, G.D. & MCCORMACK, J.G. (1997). Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc. Res., 34, 25-33.
35. VOSPER, H., KHOUDOLI, G.A., GRAHAM, T.L. & PALMER, C.N. (2002). Peroxisome proliferator-activated receptor agonists, hyperlipidaemia, and atherosclerosis. Pharmacol. Ther., 95, 47-62.
36. WANG, P.G., LLOYD, S.G., ZENG, H., BONEN, A. & CHATHAM, J.C. (2004). The impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats. Am. J. Physiol. Heart. Circ. Physiol., in press.
37. YOSHIKAWA, T., IDE, T., SHIMANO, H., YAHAGI, N., AMEMIYAKUDO, M., MATSUZAKA, T., YATOH, S., KITAMINE, T., OKAZAKI, H., TAMURA, Y., SEKIYA, M., TAKAHASHI, A., HASTY, A.H., SATO, R., SONE, H., OSUGA, J., ISHIBASHI, S. & YAMADA, N. (2003). Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling. Mol. Endocrinol., 17, 1240-1254.
38. ZHOU, Y.T., GRAYBURN, P., KARIM, A., SHIMABUKURO, M., HIGA, M., BAETENS, D., ORCI, L. & UNGER, R.H. (2000). Lipotoxic heart disease in obese rats: implications for human obesity. Proc. Natl. Acad. Sci. U.S.A., 97, 1784-1789.
39. ZHOU, Y.T., SHIMABUKURO, M., WANG, M.Y., LEE, Y., HIGA, M., MILBURN, J.L., NEWGARD, C.B. & UNGER, R.H. (1998). Role of peroxisome proliferator-activated receptor alpha in disease of pancreatic beta cells. Proc. Natl. Acad. Sci. U.S.A., 95, 8898-8903.